CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Northern Arizona Healthcare

Travis Boren, Director, Provider Integration and Virtual Care

"Brick and Mortar is Dead"

Travis Boren

Travis Boren

Brick and Mortar is Dead’ and similar proclamations dotted the headlines of every retail banking industry magazine, periodical, blog and news article 10 to 15years ago. The proclamations made the bold prediction that bank branches would disappear as a new breed of digital banking tools such as online and mobile bankingtook center stage.Yet, here we are 15 years later and most of us can stand on a corner of any city or town, big and small, and throw a rock and hit a bank branch. However, upon closer look, you will notice that the local bank branch has evolved significantly.


As a recovering banker, who found his calling in healthcare after spending time in the software industry, I can’t help but draw parallels between what is occurring in healthcare with regard to digital health and virtual care and the transformation that has occurred in many industries in the last couple of decades.


When evaluating what the future holds, we can look to industries that have undergone this evolution and transformation years before the current pandemic forced healthcare to look itself in the mirror regarding digital transformation and virtual care delivery.Bank branches are not in danger of going extinct, they are just evolving.What we have seen, however, is the demise of banking organizations that were not willing to transform and evolve quickly with changing consumer behavior and demands.This should serve as a wakeup call for healthcare systems and provider practices across the US.


An omni-channel approach weaves both physical and digital channels harmoniously to ensure a consistent and uninterrupted experience for the patient.


In the days, months, and (heavy sigh) years that have lapsed since the onset of the COVID-19 pandemic, it’s hard to avoid allusions and proclamations regarding the future of in-person care and brick and mortar clinics.The rapid adoption of virtual care has prompted some to prophesize dire outcomes for inperson care.This is not an either/or situation when comparing virtual vs. in-person, but rather ‘both’—aligned with the objective of increasing value, improving care and decreasing costs.


It is imperative that healthcare organizations rapidly evolve care delivery and seek to digitally transform their organizations. The banking industry has largely evolved to offer consumers an omni-channel experience that promotes a unified experience to access services through the consumer’s preferred channel.As healthcare providers, there is great opportunity to leverage this same omni-channel approach to help us achieve objectives of providing greater value, improving outcomes, increasing patient satisfaction and reducing costs. We must meet our patients where they are, and proactively deliver the customized care they need whether it’s care by video, care in the clinic, care at the retail kiosk, scheduling on mobile, proactive monitoring of vitals via wearable devices, triage and navigation via AI assistant and the list goes on.


An omni-channel approach weaves both physical and digital channels harmoniously to ensure a consistent and uninterrupted experience for the patient.It is also important to note that a successful omni-channel approach optimizes and automates staff and clinician workflows and garners increased engagement of our workforce. Digital health and virtual care should augment the care experience for all patients, staffand clinicians, or else adoption will suffer greatly.


Healthcare is fatigued from the pandemic these past few years and the thought of a significant initiative can be daunting.However, a wellcrafted strategy for the modernization of digital health and virtual care capabilities can offer a powerful opportunity to improve patient satisfaction, while also decreasing the heavy burden and burnout thatstaff are experiencing through this difficult time.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/leadership-perspective/travis-boren-nwid-3036.html